Interchange Capital Partners LLC Makes New Investment in Medicus Pharma Ltd. (NASDAQ:MDCX)

Interchange Capital Partners LLC acquired a new position in shares of Medicus Pharma Ltd. (NASDAQ:MDCX) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 1,457,165 shares of the company’s stock, valued at approximately $3,628,000. Medicus Pharma comprises about 1.3% of Interchange Capital Partners LLC’s portfolio, making the stock its 15th biggest position. Interchange Capital Partners LLC owned about 13.43% of Medicus Pharma as of its most recent SEC filing.

Analysts Set New Price Targets

Several brokerages have weighed in on MDCX. Brookline Capital Management raised Medicus Pharma to a “strong-buy” rating in a research note on Monday, December 23rd. Maxim Group began coverage on Medicus Pharma in a research note on Tuesday, December 17th. They set a “buy” rating and a $10.00 price objective on the stock.

Medicus Pharma Stock Down 4.9 %

Shares of NASDAQ:MDCX opened at $3.32 on Monday. Medicus Pharma Ltd. has a 1 year low of $1.80 and a 1 year high of $6.00. The company’s 50 day simple moving average is $3.16.

Medicus Pharma Company Profile

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.